These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1624802)

  • 21. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
    Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S
    Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC; Kaushal NA; Narula A; Kumar N; Puri SK; Dutta S; Lanar DE
    Indian J Biochem Biophys; 2007 Dec; 44(6):429-36. PubMed ID: 18320841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pf332-C231-reactive antibodies affect growth and development of intra-erythrocytic Plasmodium falciparum parasites.
    Balogun HA; Awah NW; Farouk SE; Berzins K
    Vaccine; 2011 Dec; 30(1):21-8. PubMed ID: 22064263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
    Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
    Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems.
    Bathurst IC; Gibson HL; Kansopon J; Hahm BK; Hollingdale MR; Barr PJ
    Biotechnol Ther; 1992; 3(1-2):15-34. PubMed ID: 1305890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of disulfide bonds in Plasmodium falciparum gp195 abolishes the production of growth-inhibitory antibodies.
    Locher CP; Tam LQ
    Vaccine; 1993; 11(11):1119-23. PubMed ID: 8249430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.
    Hui GS; Hashimoto A; Chang SP
    Infect Immun; 1992 Apr; 60(4):1422-33. PubMed ID: 1548068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.
    Chang SP; Hui GS; Kato A; Siddiqui WA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6343-7. PubMed ID: 2668963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of inhibitory epitopes in the Plasmodium falciparum rhoptry protein RAP-1 including identification of a second inhibitory epitope.
    Howard RF; Jacobson KC; Rickel E; Thurman J
    Infect Immun; 1998 Jan; 66(1):380-6. PubMed ID: 9423886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.
    Pang AL; Hashimoto CN; Tam LQ; Meng ZQ; Hui GS; Ho WK
    Infect Immun; 2002 Jun; 70(6):2772-9. PubMed ID: 12010962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
    Leung WH; Meng ZQ; Hui G; Ho WK
    Biochim Biophys Acta; 2004 Nov; 1675(1-3):62-70. PubMed ID: 15535968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein.
    Liang H; Narum DL; Fuhrmann SR; Luu T; Sim BK
    Infect Immun; 2000 Jun; 68(6):3564-8. PubMed ID: 10816512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
    Daly TM; Long CA
    Infect Immun; 1993 Jun; 61(6):2462-7. PubMed ID: 8363656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and characterization of monoclonal antibody specific to PfCP-2.9 chimeric protein of Plasmodium falciparum].
    Wang R; Qian F; Qu L; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Aug; 24(4):247-50. PubMed ID: 17094589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.
    Etlinger HM; Caspers P; Matile H; Schoenfeld HJ; Stueber D; Takacs B
    Infect Immun; 1991 Oct; 59(10):3498-503. PubMed ID: 1894356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1).
    Blackman MJ; Holder AA
    FEMS Immunol Med Microbiol; 1993 Apr; 6(4):307-15. PubMed ID: 7684635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.
    Moreno R; Pöltl-Frank F; Stüber D; Matile H; Mutz M; Weiss NA; Pluschke G
    Infect Immun; 2001 Apr; 69(4):2558-68. PubMed ID: 11254620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.